Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy.
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Rituximab (Primary) ; Adalimumab; Etanercept
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ORBIT
- 28 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 18 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
- 14 Dec 2013 Accrual to date is 112% according to United Kingdom Clinical Research Network.